• $4.1M
    Market Cap
  • -83.23%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
36.3M
+4.11%
34.9M
+44.75%
24.1M
+454.42%
4.3M
+1,802.41%
Cost of Revenue
24.1M
-0.64%
24.2M
+53.64%
15.8M
+494.69%
2.6M
+2,148.18%
Gross Profit
12.3M
+14.86%
10.7M
+27.95%
8.3M
+391.53%
1.7M
+1,434.03%
Sales and Marketing Expense
1.1M
+21.66%
940,278
+28.06%
734,248
+27.01%
578,085
N/A
Research and Development Expense
-604,308
-35.29%
-933,902
-49.68%
-1.9M
+128.59%
-811,858
+20.77%
Depreciation and Amortization Expense
332,070
+48.56%
223,527
+49.87%
149,147
+492.72%
25,163
+97.50%
Total Operating Expenses
18.5M
+12.14%
16.5M
+25.58%
13.1M
-54.27%
28.7M
+1,025.06%
Operating Profit
-6.2M
+7.14%
-5.8M
+21.46%
-4.8M
-82.28%
-27.0M
+1,006.53%
Interest Income
280,901
-43.37%
496,003
-38.91%
811,974
+56.56%
518,650
N/A
Interest Expense
N/A
N/A
N/A
N/A
-137,308
+248.39%
-39,412
-88.01%
Interest Income and Expense and Net
280,901
-43.37%
496,003
-26.48%
674,666
+40.78%
479,238
+245.75%
Total Nonoperating Income and Expense
273,286
-38.33%
443,147
-34.29%
674,421
+37.75%
489,614
+104.90%
Income before Taxes
-6.0M
+10.89%
-5.4M
+30.60%
-4.1M
-84.49%
-26.5M
+113.17%
Income Taxes
21,609
+109.20%
-234,858
-159.43%
395,166
+69.38%
233,304
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-6.0M
+16.39%
-5.1M
+13.94%
-4.5M
-83.15%
-26.7M
+115.05%
Net Income from Continuing Operations Applicable to Common
-6.0M
+10.89%
-5.4M
+30.60%
-4.1M
-84.49%
-26.5M
+113.17%
Basic EPS and Net Income
-1.44
-80.33%
-7.32
+3,752.63%
-0.19
-89.20%
-1.76
-63.03%
Diluted EPS and Net Income
-1.44
-80.33%
-7.32
+3,752.63%
-0.19
-89.20%
-1.76
-63.03%
Basic Weighted Average Shares
4.2M
+492.39%
701,749
-97.12%
24.3M
+60.28%
15.2M
+481.18%
Diluted Weighted Average Shares
4.2M
+492.39%
701,749
-97.12%
24.3M
+60.28%
15.2M
+481.18%
Balance Sheet
Cash and Cash Equivalents
9.1M
-5.81%
9.7M
-40.55%
16.3M
-25.35%
21.8M
+967.22%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
9.1M
-5.81%
9.7M
-40.55%
16.3M
-25.35%
21.8M
+967.22%
Total Current Assets
26.9M
+3.42%
26.0M
+4.32%
24.9M
-8.87%
27.3M
+1,143.83%
Accumulated Depreciation
512,879
+52.40%
336,533
+77.13%
189,996
N/A
N/A
N/A
Property and Plant and Equipment and Net
557,370
+2.07%
546,055
+49.25%
365,868
-7.20%
394,249
+5,483.47%
Total Long-Term Assets
3.2M
-29.79%
4.6M
+1,155.66%
365,868
-7.20%
394,249
+5,483.47%
Total Assets
30.1M
-1.57%
30.6M
+11.75%
27.3M
-6.49%
29.2M
+1,227.52%
Income Taxes Payable
268,276
0.00%
268,276
-10.54%
299,869
-19.65%
373,191
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
6.4M
+2.04%
6.3M
+13.74%
5.6M
-19.90%
6.9M
+7,497.38%
Total Long-Term Debt
0
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Total Long-Term Liabilities
596,785
-19.86%
744,724
+26.70%
587,764
-14.23%
685,264
-63.93%
Total Liabilities
7.0M
-0.27%
7.1M
+14.99%
6.1M
-19.39%
7.6M
+282.49%
Retained Earnings
-75.0M
+8.65%
-69.0M
+8.03%
-63.9M
+7.59%
-59.4M
+81.90%
Total Stockholders Equity
23.0M
-1.97%
23.5M
+10.81%
21.2M
-1.94%
21.6M
+10,117.97%
Total Shares Outstanding
4.9M
+90.15%
2.6M
-90.79%
28.0M
+24.08%
22.6M
+771.61%
Cash Flow
Cash from Operating Activities
-5.3M
-57.46%
-12.5M
+42.80%
-8.8M
+67.20%
-5.2M
+186.93%
Capital Expenditures
174,491
-89.47%
1.7M
+1,914.63%
82,251
-57.60%
193,982
N/A
Cash from Investing Activities
-836,306
-63.97%
-2.3M
+253.71%
-656,150
-95.51%
-14.6M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
4.7M
-48.88%
9.3M
+171.18%
3.4M
-91.32%
39.5M
+1,258.68%
Financials Ratio
Gross Margin
33.76%
+10.33%
30.60%
-11.61%
34.61%
-11.34%
39.04%
-19.36%
Operating Margin
-17.15%
+2.91%
-16.67%
-16.09%
-19.86%
-96.80%
-621.33%
-41.84%
Return on Assets
-19.71%
+11.14%
-17.73%
+11.35%
-15.92%
-90.64%
-170.09%
-77.79%
Return on Equity
-25.68%
+11.81%
-22.97%
+9.16%
-21.04%
-91.41%
-244.92%
-107.32%
Revenue Growth
4.11%
-90.83%
44.75%
-90.15%
454.42%
-74.79%
1,802.41%
+719.73%
Current Ratio
4.17
+1.35%
4.11
-8.28%
4.48
+13.77%
3.94
-83.63%
Cash Ratio
1.42
-7.70%
1.53
-47.73%
2.93
-6.81%
3.15
-85.95%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow